mRNA: Decoding the Future Beyond Vaccines
Self-Amplifying RNA: Redefining RNA-Based Therapeutics The global RNA therapeutics market is slated to reach $940-$950 million by 2035. Out of several promising advancements driving this growth, self-amplifying RNA therapeutics are currently leading the pack. saRNA vaccines offer protective immunity at doses that are 1,000,000-fold lower than their mRNA counterparts, with optimized platforms in preclinical models. […]
The Expanding Role Of Self-Amplifying RNA In Therapeutics
The approval of KOSTAIVE by Arcturus Therapeutics and CSL by the European Medicines Agency (EMA) marked the next chapter in the growing impact of mRNA vaccines worldwide. KOSTAIVE, however, is also a step ahead of the traditional mRNA vaccines. It is embedded with self-amplifying RNA (saRNA) that supersedes its standard counterpart in several ways. Though […]